Use of qualitative integrative cycler PCR (qicPCR) to identify optimal therapeutic dosing time-points in a Respiratory Syncytial Virus Human Viral Challenge Model (hVCM)

导出原文传递

翻译打印收藏纠错

作者： Kelly, Geraldine ^[1] ; Laxton, Carl ^[1] ; Garelnabi, Mariam ^[1] ; Alton, Brian ^[1] ; Addan, Fatima ^[1] ; Catchpole, Andrew ^[1] ; Thomas, Elaine ^[1] ; Borley, Daryl ^[1] ; Dee, Kieran ^[1] ; Boyers, Alison ^[1] ; Bringas, Erica ^[1] ; Noulin, Nicolas ^[1] ; Lambkin-Williams, Rob ^[1] ; Murray, Edward J. ^[1]

作者单位： Queen Mary BioEnterprises Innovat Ctr, Retroscreen Virol Ltd hVIVO, London E1 2AX, England ^[1]

关键词 qicPCR RSV challenge model (hVCM)RSV clinical trials

发布时间 2015-11-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Virological Methods

2015年224卷

83-90页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Use of qualitative integrative cycler PCR (qicPCR) to identify optimal therapeutic dosing time-points in a Respiratory Syncytial Virus Human Viral Challenge Model (hVCM)

Journal of Virological Methods

相似文献

Journal of Virological Methods

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Use of qualitative integrative cycler PCR (qicPCR) to identify optimal therapeutic dosing time-points in a Respiratory Syncytial Virus Human Viral Challenge Model (hVCM)

Journal of Virological Methods

相似文献

Journal of Virological Methods

相关期刊

检索历史清除